When platform processes are applied to fusion molecules, innovation and flexibility are needed.
Douglas W. Rea
Advertisement
Senior Specialist of Downstream Process Development at Laureate Pharma, Inc.
Articles by Douglas W. Rea
Advertisement
Latest Updated Articles
Solutions for Purification of Fc-fusion ProteinsPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
Welcome to CPHI Frankfurt 2025
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
